Angiodynamic Inc (NASDAQ: ANGO) is -2.42% lower on its value in year-to-date trading and has touched a low of $5.26 and a high of $8.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ANGO stock was last observed hovering at around $7.63 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $7.65, the stock is 1.92% and 1.67% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.73 million and changing 0.26% at the moment leaves the stock 17.14% off its SMA200. ANGO registered 2.82% gain for a year compared to 6-month gain of 25.82%. The firm has a 50-day simple moving average (SMA 50) of $7.5274 and a 200-day simple moving average (SMA200) of $6.5314.
The stock witnessed a 4.51% loss in the last 1 month and extending the period to 3 months gives it a 34.68%, and is 3.38% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.86% over the week and 3.33% over the month.
Angiodynamic Inc (ANGO) has around 748 employees, a market worth around $310.82M and $303.91M in sales. Profit margin for the company is -60.66%. Distance from 52-week low is 45.44% and -7.27% from its 52-week high. The company has generated returns on investments over the last 12 months (-87.98%).
The EPS is expected to shrink by -7.02% this year
186.0 institutions hold shares in Angiodynamic Inc (ANGO), with institutional investors hold 86.51% of the company’s shares. The shares outstanding are 40.43M, and float is at 38.24M with Short Float at 3.26%. Institutions hold 81.82% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 4.6 million shares valued at $27.86 million. The investor’s holdings represent 11.4443 of the ANGO Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.19 million shares valued at $13.25 million to account for 5.4418 of the shares outstanding. The other top investors are SYSTEMATIC FINANCIAL MANAGEMENT LP which holds 2.11 million shares representing 5.2432 and valued at over $12.76 million, while MILLENNIUM MANAGEMENT LLC holds 4.4576 of the shares totaling 1.79 million with a market value of $10.85 million.
Angiodynamic Inc (ANGO) Insider Activity
The most recent transaction is an insider purchase by Clemmer James C, the company’s President and CEO. SEC filings show that Clemmer James C bought 10,000 shares of the company’s common stock on Apr 08 ’24 at a price of $6.70 per share for a total of $67000.0. Following the purchase, the insider now owns 0.54 million shares.
